nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—UGT2B7—Epirubicin—uterine cancer	0.214	0.397	CbGbCtD
Etodolac—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0992	0.184	CbGbCtD
Etodolac—PTGS2—Etoposide—uterine cancer	0.0865	0.161	CbGbCtD
Etodolac—PTGS1—Etoposide—uterine cancer	0.0731	0.136	CbGbCtD
Etodolac—CYP2C9—Progesterone—uterine cancer	0.0657	0.122	CbGbCtD
Etodolac—UGT1A10—renal system—uterine cancer	0.00633	0.128	CbGeAlD
Etodolac—RXRA—renal system—uterine cancer	0.00377	0.0762	CbGeAlD
Etodolac—PTGS1—oviduct—uterine cancer	0.00359	0.0724	CbGeAlD
Etodolac—UGT1A9—renal system—uterine cancer	0.00318	0.0642	CbGeAlD
Etodolac—RXRA—female reproductive system—uterine cancer	0.00302	0.061	CbGeAlD
Etodolac—RXRA—female gonad—uterine cancer	0.00275	0.0555	CbGeAlD
Etodolac—UGT2B7—renal system—uterine cancer	0.00256	0.0517	CbGeAlD
Etodolac—PTGS1—artery—uterine cancer	0.00238	0.048	CbGeAlD
Etodolac—PTGS2—artery—uterine cancer	0.00227	0.0458	CbGeAlD
Etodolac—UGT2B7—female reproductive system—uterine cancer	0.00205	0.0414	CbGeAlD
Etodolac—PTGS2—myometrium—uterine cancer	0.0011	0.0221	CbGeAlD
Etodolac—PTGS1—epithelium—uterine cancer	0.000901	0.0182	CbGeAlD
Etodolac—PTGS1—uterine cervix—uterine cancer	0.000893	0.018	CbGeAlD
Etodolac—PTGS1—smooth muscle tissue—uterine cancer	0.000868	0.0175	CbGeAlD
Etodolac—PTGS2—epithelium—uterine cancer	0.000861	0.0174	CbGeAlD
Etodolac—PTGS2—uterine cervix—uterine cancer	0.000854	0.0172	CbGeAlD
Etodolac—PTGS1—renal system—uterine cancer	0.000835	0.0169	CbGeAlD
Etodolac—PTGS2—smooth muscle tissue—uterine cancer	0.00083	0.0168	CbGeAlD
Etodolac—PTGS1—endometrium—uterine cancer	0.000808	0.0163	CbGeAlD
Etodolac—PTGS2—renal system—uterine cancer	0.000799	0.0161	CbGeAlD
Etodolac—PTGS1—mammalian vulva—uterine cancer	0.000781	0.0158	CbGeAlD
Etodolac—PTGS2—endometrium—uterine cancer	0.000772	0.0156	CbGeAlD
Etodolac—PTGS1—uterus—uterine cancer	0.000744	0.015	CbGeAlD
Etodolac—CYP2C9—female reproductive system—uterine cancer	0.000733	0.0148	CbGeAlD
Etodolac—PTGS2—uterus—uterine cancer	0.000711	0.0144	CbGeAlD
Etodolac—ALB—lymph node—uterine cancer	0.000687	0.0139	CbGeAlD
Etodolac—PTGS1—female reproductive system—uterine cancer	0.000669	0.0135	CbGeAlD
Etodolac—PTGS2—female reproductive system—uterine cancer	0.00064	0.0129	CbGeAlD
Etodolac—PTGS1—female gonad—uterine cancer	0.000609	0.0123	CbGeAlD
Etodolac—PTGS1—vagina—uterine cancer	0.000605	0.0122	CbGeAlD
Etodolac—PTGS2—female gonad—uterine cancer	0.000582	0.0118	CbGeAlD
Etodolac—PTGS2—vagina—uterine cancer	0.000578	0.0117	CbGeAlD
Etodolac—PTGS1—lymph node—uterine cancer	0.000391	0.0079	CbGeAlD
Etodolac—PTGS2—lymph node—uterine cancer	0.000374	0.00755	CbGeAlD
Etodolac—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00036	0.0012	CcSEcCtD
Etodolac—Hepatic failure—Doxorubicin—uterine cancer	0.000359	0.00119	CcSEcCtD
Etodolac—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000358	0.00119	CcSEcCtD
Etodolac—Cerebrovascular accident—Epirubicin—uterine cancer	0.000356	0.00118	CcSEcCtD
Etodolac—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000356	0.00118	CcSEcCtD
Etodolac—Nausea—Progesterone—uterine cancer	0.000355	0.00118	CcSEcCtD
Etodolac—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000349	0.00116	CcSEcCtD
Etodolac—Feeling abnormal—Dactinomycin—uterine cancer	0.000348	0.00116	CcSEcCtD
Etodolac—Ill-defined disorder—Etoposide—uterine cancer	0.000347	0.00115	CcSEcCtD
Etodolac—Anaemia—Etoposide—uterine cancer	0.000346	0.00115	CcSEcCtD
Etodolac—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000345	0.00115	CcSEcCtD
Etodolac—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000344	0.00114	CcSEcCtD
Etodolac—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000342	0.00114	CcSEcCtD
Etodolac—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000341	0.00113	CcSEcCtD
Etodolac—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000341	0.00113	CcSEcCtD
Etodolac—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000339	0.00113	CcSEcCtD
Etodolac—Renal impairment—Doxorubicin—uterine cancer	0.000339	0.00113	CcSEcCtD
Etodolac—Malaise—Etoposide—uterine cancer	0.000338	0.00112	CcSEcCtD
Etodolac—Dermatitis bullous—Doxorubicin—uterine cancer	0.000337	0.00112	CcSEcCtD
Etodolac—Vertigo—Etoposide—uterine cancer	0.000336	0.00112	CcSEcCtD
Etodolac—Leukopenia—Etoposide—uterine cancer	0.000335	0.00111	CcSEcCtD
Etodolac—Purpura—Doxorubicin—uterine cancer	0.000335	0.00111	CcSEcCtD
Etodolac—Body temperature increased—Dactinomycin—uterine cancer	0.000334	0.00111	CcSEcCtD
Etodolac—Abdominal pain—Dactinomycin—uterine cancer	0.000334	0.00111	CcSEcCtD
Etodolac—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000333	0.00111	CcSEcCtD
Etodolac—Loss of consciousness—Etoposide—uterine cancer	0.000329	0.00109	CcSEcCtD
Etodolac—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000329	0.00109	CcSEcCtD
Etodolac—Convulsion—Etoposide—uterine cancer	0.000324	0.00108	CcSEcCtD
Etodolac—Hypertension—Etoposide—uterine cancer	0.000323	0.00107	CcSEcCtD
Etodolac—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000322	0.00107	CcSEcCtD
Etodolac—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000322	0.00107	CcSEcCtD
Etodolac—Abdominal pain upper—Epirubicin—uterine cancer	0.000318	0.00106	CcSEcCtD
Etodolac—Discomfort—Etoposide—uterine cancer	0.000315	0.00105	CcSEcCtD
Etodolac—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000314	0.00104	CcSEcCtD
Etodolac—Hypersensitivity—Dactinomycin—uterine cancer	0.000311	0.00103	CcSEcCtD
Etodolac—Gastritis—Epirubicin—uterine cancer	0.000308	0.00102	CcSEcCtD
Etodolac—Confusional state—Etoposide—uterine cancer	0.000308	0.00102	CcSEcCtD
Etodolac—Anaphylactic shock—Etoposide—uterine cancer	0.000306	0.00102	CcSEcCtD
Etodolac—Infection—Etoposide—uterine cancer	0.000304	0.00101	CcSEcCtD
Etodolac—Abdominal distension—Epirubicin—uterine cancer	0.000303	0.00101	CcSEcCtD
Etodolac—Asthenia—Dactinomycin—uterine cancer	0.000303	0.00101	CcSEcCtD
Etodolac—Asthma—Epirubicin—uterine cancer	0.000301	0.001	CcSEcCtD
Etodolac—Thrombocytopenia—Etoposide—uterine cancer	0.000299	0.000994	CcSEcCtD
Etodolac—Tachycardia—Etoposide—uterine cancer	0.000298	0.000991	CcSEcCtD
Etodolac—Eosinophilia—Epirubicin—uterine cancer	0.000298	0.000991	CcSEcCtD
Etodolac—Hyperhidrosis—Etoposide—uterine cancer	0.000295	0.000981	CcSEcCtD
Etodolac—Pancreatitis—Epirubicin—uterine cancer	0.000295	0.000981	CcSEcCtD
Etodolac—Abdominal pain upper—Doxorubicin—uterine cancer	0.000295	0.000978	CcSEcCtD
Etodolac—Anorexia—Etoposide—uterine cancer	0.000291	0.000968	CcSEcCtD
Etodolac—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00029	0.000965	CcSEcCtD
Etodolac—Bronchitis—Epirubicin—uterine cancer	0.00029	0.000962	CcSEcCtD
Etodolac—Diarrhoea—Dactinomycin—uterine cancer	0.000289	0.00096	CcSEcCtD
Etodolac—Pancytopenia—Epirubicin—uterine cancer	0.000286	0.00095	CcSEcCtD
Etodolac—Hypotension—Etoposide—uterine cancer	0.000286	0.000949	CcSEcCtD
Etodolac—Gastritis—Doxorubicin—uterine cancer	0.000285	0.000948	CcSEcCtD
Etodolac—Dysuria—Epirubicin—uterine cancer	0.000282	0.000936	CcSEcCtD
Etodolac—Neutropenia—Epirubicin—uterine cancer	0.000282	0.000936	CcSEcCtD
Etodolac—Abdominal distension—Doxorubicin—uterine cancer	0.000281	0.000932	CcSEcCtD
Etodolac—Asthma—Doxorubicin—uterine cancer	0.000279	0.000926	CcSEcCtD
Etodolac—Pollakiuria—Epirubicin—uterine cancer	0.000278	0.000924	CcSEcCtD
Etodolac—Eosinophilia—Doxorubicin—uterine cancer	0.000276	0.000917	CcSEcCtD
Etodolac—Photosensitivity reaction—Epirubicin—uterine cancer	0.000275	0.000913	CcSEcCtD
Etodolac—Paraesthesia—Etoposide—uterine cancer	0.000274	0.000912	CcSEcCtD
Etodolac—Pancreatitis—Doxorubicin—uterine cancer	0.000273	0.000908	CcSEcCtD
Etodolac—Dyspnoea—Etoposide—uterine cancer	0.000272	0.000905	CcSEcCtD
Etodolac—Hyperglycaemia—Epirubicin—uterine cancer	0.000272	0.000903	CcSEcCtD
Etodolac—Somnolence—Etoposide—uterine cancer	0.000272	0.000903	CcSEcCtD
Etodolac—Pneumonia—Epirubicin—uterine cancer	0.00027	0.000897	CcSEcCtD
Etodolac—Vomiting—Dactinomycin—uterine cancer	0.000268	0.000892	CcSEcCtD
Etodolac—Bronchitis—Doxorubicin—uterine cancer	0.000268	0.00089	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000266	0.000885	CcSEcCtD
Etodolac—Rash—Dactinomycin—uterine cancer	0.000266	0.000884	CcSEcCtD
Etodolac—Decreased appetite—Etoposide—uterine cancer	0.000266	0.000882	CcSEcCtD
Etodolac—Pancytopenia—Doxorubicin—uterine cancer	0.000265	0.000879	CcSEcCtD
Etodolac—Renal failure—Epirubicin—uterine cancer	0.000264	0.000877	CcSEcCtD
Etodolac—Fatigue—Etoposide—uterine cancer	0.000263	0.000875	CcSEcCtD
Etodolac—Jaundice—Epirubicin—uterine cancer	0.000262	0.00087	CcSEcCtD
Etodolac—Stomatitis—Epirubicin—uterine cancer	0.000262	0.00087	CcSEcCtD
Etodolac—Pain—Etoposide—uterine cancer	0.000261	0.000868	CcSEcCtD
Etodolac—Constipation—Etoposide—uterine cancer	0.000261	0.000868	CcSEcCtD
Etodolac—Conjunctivitis—Epirubicin—uterine cancer	0.000261	0.000867	CcSEcCtD
Etodolac—Neutropenia—Doxorubicin—uterine cancer	0.000261	0.000866	CcSEcCtD
Etodolac—Dysuria—Doxorubicin—uterine cancer	0.000261	0.000866	CcSEcCtD
Etodolac—Sweating—Epirubicin—uterine cancer	0.000257	0.000855	CcSEcCtD
Etodolac—Pollakiuria—Doxorubicin—uterine cancer	0.000257	0.000855	CcSEcCtD
Etodolac—Haematuria—Epirubicin—uterine cancer	0.000256	0.000851	CcSEcCtD
Etodolac—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000254	0.000845	CcSEcCtD
Etodolac—Sinusitis—Epirubicin—uterine cancer	0.000252	0.000837	CcSEcCtD
Etodolac—Feeling abnormal—Etoposide—uterine cancer	0.000252	0.000837	CcSEcCtD
Etodolac—Hyperglycaemia—Doxorubicin—uterine cancer	0.000251	0.000835	CcSEcCtD
Etodolac—Nausea—Dactinomycin—uterine cancer	0.000251	0.000833	CcSEcCtD
Etodolac—Agranulocytosis—Epirubicin—uterine cancer	0.000251	0.000833	CcSEcCtD
Etodolac—Pneumonia—Doxorubicin—uterine cancer	0.00025	0.00083	CcSEcCtD
Etodolac—Gastrointestinal pain—Etoposide—uterine cancer	0.00025	0.00083	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000246	0.000818	CcSEcCtD
Etodolac—Renal failure—Doxorubicin—uterine cancer	0.000244	0.000812	CcSEcCtD
Etodolac—Urticaria—Etoposide—uterine cancer	0.000243	0.000806	CcSEcCtD
Etodolac—Haemoglobin—Epirubicin—uterine cancer	0.000242	0.000805	CcSEcCtD
Etodolac—Jaundice—Doxorubicin—uterine cancer	0.000242	0.000805	CcSEcCtD
Etodolac—Stomatitis—Doxorubicin—uterine cancer	0.000242	0.000805	CcSEcCtD
Etodolac—Rhinitis—Epirubicin—uterine cancer	0.000242	0.000803	CcSEcCtD
Etodolac—Body temperature increased—Etoposide—uterine cancer	0.000242	0.000803	CcSEcCtD
Etodolac—Abdominal pain—Etoposide—uterine cancer	0.000242	0.000803	CcSEcCtD
Etodolac—Conjunctivitis—Doxorubicin—uterine cancer	0.000242	0.000802	CcSEcCtD
Etodolac—Hepatitis—Epirubicin—uterine cancer	0.000241	0.000801	CcSEcCtD
Etodolac—Haemorrhage—Epirubicin—uterine cancer	0.000241	0.000801	CcSEcCtD
Etodolac—Pharyngitis—Epirubicin—uterine cancer	0.000239	0.000795	CcSEcCtD
Etodolac—Sweating—Doxorubicin—uterine cancer	0.000238	0.000791	CcSEcCtD
Etodolac—Haematuria—Doxorubicin—uterine cancer	0.000237	0.000787	CcSEcCtD
Etodolac—Sinusitis—Doxorubicin—uterine cancer	0.000233	0.000775	CcSEcCtD
Etodolac—Visual impairment—Epirubicin—uterine cancer	0.000232	0.000772	CcSEcCtD
Etodolac—Agranulocytosis—Doxorubicin—uterine cancer	0.000232	0.00077	CcSEcCtD
Etodolac—Erythema multiforme—Epirubicin—uterine cancer	0.000228	0.000757	CcSEcCtD
Etodolac—Hypersensitivity—Etoposide—uterine cancer	0.000225	0.000748	CcSEcCtD
Etodolac—Tinnitus—Epirubicin—uterine cancer	0.000225	0.000747	CcSEcCtD
Etodolac—Haemoglobin—Doxorubicin—uterine cancer	0.000224	0.000745	CcSEcCtD
Etodolac—Flushing—Epirubicin—uterine cancer	0.000224	0.000743	CcSEcCtD
Etodolac—Rhinitis—Doxorubicin—uterine cancer	0.000224	0.000743	CcSEcCtD
Etodolac—Haemorrhage—Doxorubicin—uterine cancer	0.000223	0.000741	CcSEcCtD
Etodolac—Hepatitis—Doxorubicin—uterine cancer	0.000223	0.000741	CcSEcCtD
Etodolac—Pharyngitis—Doxorubicin—uterine cancer	0.000221	0.000736	CcSEcCtD
Etodolac—Asthenia—Etoposide—uterine cancer	0.000219	0.000728	CcSEcCtD
Etodolac—Chills—Epirubicin—uterine cancer	0.000216	0.000719	CcSEcCtD
Etodolac—Pruritus—Etoposide—uterine cancer	0.000216	0.000718	CcSEcCtD
Etodolac—Arrhythmia—Epirubicin—uterine cancer	0.000215	0.000716	CcSEcCtD
Etodolac—Visual impairment—Doxorubicin—uterine cancer	0.000215	0.000714	CcSEcCtD
Etodolac—Alopecia—Epirubicin—uterine cancer	0.000213	0.000708	CcSEcCtD
Etodolac—Erythema multiforme—Doxorubicin—uterine cancer	0.000211	0.000701	CcSEcCtD
Etodolac—Diarrhoea—Etoposide—uterine cancer	0.000209	0.000695	CcSEcCtD
Etodolac—Tinnitus—Doxorubicin—uterine cancer	0.000208	0.000691	CcSEcCtD
Etodolac—Flushing—Doxorubicin—uterine cancer	0.000207	0.000688	CcSEcCtD
Etodolac—Flatulence—Epirubicin—uterine cancer	0.000207	0.000687	CcSEcCtD
Etodolac—Tension—Epirubicin—uterine cancer	0.000206	0.000684	CcSEcCtD
Etodolac—Dysgeusia—Epirubicin—uterine cancer	0.000206	0.000683	CcSEcCtD
Etodolac—Nervousness—Epirubicin—uterine cancer	0.000204	0.000677	CcSEcCtD
Etodolac—Dizziness—Etoposide—uterine cancer	0.000202	0.000671	CcSEcCtD
Etodolac—Chills—Doxorubicin—uterine cancer	0.0002	0.000665	CcSEcCtD
Etodolac—Arrhythmia—Doxorubicin—uterine cancer	0.000199	0.000662	CcSEcCtD
Etodolac—Vision blurred—Epirubicin—uterine cancer	0.000198	0.000657	CcSEcCtD
Etodolac—Alopecia—Doxorubicin—uterine cancer	0.000197	0.000655	CcSEcCtD
Etodolac—Ill-defined disorder—Epirubicin—uterine cancer	0.000195	0.000647	CcSEcCtD
Etodolac—Vomiting—Etoposide—uterine cancer	0.000194	0.000645	CcSEcCtD
Etodolac—Anaemia—Epirubicin—uterine cancer	0.000194	0.000644	CcSEcCtD
Etodolac—Rash—Etoposide—uterine cancer	0.000193	0.00064	CcSEcCtD
Etodolac—Dermatitis—Etoposide—uterine cancer	0.000192	0.00064	CcSEcCtD
Etodolac—Headache—Etoposide—uterine cancer	0.000191	0.000636	CcSEcCtD
Etodolac—Flatulence—Doxorubicin—uterine cancer	0.000191	0.000636	CcSEcCtD
Etodolac—Tension—Doxorubicin—uterine cancer	0.000191	0.000633	CcSEcCtD
Etodolac—Dysgeusia—Doxorubicin—uterine cancer	0.00019	0.000632	CcSEcCtD
Etodolac—Malaise—Epirubicin—uterine cancer	0.000189	0.000629	CcSEcCtD
Etodolac—Nervousness—Doxorubicin—uterine cancer	0.000189	0.000627	CcSEcCtD
Etodolac—Vertigo—Epirubicin—uterine cancer	0.000189	0.000626	CcSEcCtD
Etodolac—Syncope—Epirubicin—uterine cancer	0.000188	0.000625	CcSEcCtD
Etodolac—Leukopenia—Epirubicin—uterine cancer	0.000188	0.000624	CcSEcCtD
Etodolac—Palpitations—Epirubicin—uterine cancer	0.000185	0.000616	CcSEcCtD
Etodolac—Loss of consciousness—Epirubicin—uterine cancer	0.000184	0.000613	CcSEcCtD
Etodolac—Vision blurred—Doxorubicin—uterine cancer	0.000183	0.000608	CcSEcCtD
Etodolac—Convulsion—Epirubicin—uterine cancer	0.000182	0.000604	CcSEcCtD
Etodolac—Nausea—Etoposide—uterine cancer	0.000182	0.000603	CcSEcCtD
Etodolac—Hypertension—Epirubicin—uterine cancer	0.000181	0.000602	CcSEcCtD
Etodolac—Ill-defined disorder—Doxorubicin—uterine cancer	0.00018	0.000599	CcSEcCtD
Etodolac—Anaemia—Doxorubicin—uterine cancer	0.000179	0.000596	CcSEcCtD
Etodolac—Myalgia—Epirubicin—uterine cancer	0.000179	0.000594	CcSEcCtD
Etodolac—Arthralgia—Epirubicin—uterine cancer	0.000179	0.000594	CcSEcCtD
Etodolac—Anxiety—Epirubicin—uterine cancer	0.000178	0.000592	CcSEcCtD
Etodolac—Discomfort—Epirubicin—uterine cancer	0.000177	0.000587	CcSEcCtD
Etodolac—Malaise—Doxorubicin—uterine cancer	0.000175	0.000582	CcSEcCtD
Etodolac—Dry mouth—Epirubicin—uterine cancer	0.000175	0.000581	CcSEcCtD
Etodolac—Vertigo—Doxorubicin—uterine cancer	0.000174	0.00058	CcSEcCtD
Etodolac—Syncope—Doxorubicin—uterine cancer	0.000174	0.000579	CcSEcCtD
Etodolac—Leukopenia—Doxorubicin—uterine cancer	0.000174	0.000577	CcSEcCtD
Etodolac—Confusional state—Epirubicin—uterine cancer	0.000173	0.000574	CcSEcCtD
Etodolac—Palpitations—Doxorubicin—uterine cancer	0.000172	0.00057	CcSEcCtD
Etodolac—Oedema—Epirubicin—uterine cancer	0.000171	0.000569	CcSEcCtD
Etodolac—Anaphylactic shock—Epirubicin—uterine cancer	0.000171	0.000569	CcSEcCtD
Etodolac—Loss of consciousness—Doxorubicin—uterine cancer	0.000171	0.000567	CcSEcCtD
Etodolac—Infection—Epirubicin—uterine cancer	0.00017	0.000565	CcSEcCtD
Etodolac—Shock—Epirubicin—uterine cancer	0.000169	0.00056	CcSEcCtD
Etodolac—Convulsion—Doxorubicin—uterine cancer	0.000168	0.000559	CcSEcCtD
Etodolac—Thrombocytopenia—Epirubicin—uterine cancer	0.000168	0.000557	CcSEcCtD
Etodolac—Hypertension—Doxorubicin—uterine cancer	0.000168	0.000557	CcSEcCtD
Etodolac—Tachycardia—Epirubicin—uterine cancer	0.000167	0.000555	CcSEcCtD
Etodolac—Hyperhidrosis—Epirubicin—uterine cancer	0.000166	0.00055	CcSEcCtD
Etodolac—Myalgia—Doxorubicin—uterine cancer	0.000165	0.000549	CcSEcCtD
Etodolac—Arthralgia—Doxorubicin—uterine cancer	0.000165	0.000549	CcSEcCtD
Etodolac—Anxiety—Doxorubicin—uterine cancer	0.000165	0.000547	CcSEcCtD
Etodolac—Discomfort—Doxorubicin—uterine cancer	0.000163	0.000543	CcSEcCtD
Etodolac—Anorexia—Epirubicin—uterine cancer	0.000163	0.000542	CcSEcCtD
Etodolac—Dry mouth—Doxorubicin—uterine cancer	0.000162	0.000537	CcSEcCtD
Etodolac—Hypotension—Epirubicin—uterine cancer	0.00016	0.000532	CcSEcCtD
Etodolac—Confusional state—Doxorubicin—uterine cancer	0.00016	0.000531	CcSEcCtD
Etodolac—Anaphylactic shock—Doxorubicin—uterine cancer	0.000158	0.000527	CcSEcCtD
Etodolac—Oedema—Doxorubicin—uterine cancer	0.000158	0.000527	CcSEcCtD
Etodolac—Infection—Doxorubicin—uterine cancer	0.000157	0.000523	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000156	0.000518	CcSEcCtD
Etodolac—Shock—Doxorubicin—uterine cancer	0.000156	0.000518	CcSEcCtD
Etodolac—Thrombocytopenia—Doxorubicin—uterine cancer	0.000155	0.000516	CcSEcCtD
Etodolac—Insomnia—Epirubicin—uterine cancer	0.000155	0.000515	CcSEcCtD
Etodolac—Tachycardia—Doxorubicin—uterine cancer	0.000155	0.000514	CcSEcCtD
Etodolac—Paraesthesia—Epirubicin—uterine cancer	0.000154	0.000511	CcSEcCtD
Etodolac—Hyperhidrosis—Doxorubicin—uterine cancer	0.000153	0.000509	CcSEcCtD
Etodolac—Dyspnoea—Epirubicin—uterine cancer	0.000153	0.000507	CcSEcCtD
Etodolac—Somnolence—Epirubicin—uterine cancer	0.000152	0.000506	CcSEcCtD
Etodolac—Anorexia—Doxorubicin—uterine cancer	0.000151	0.000502	CcSEcCtD
Etodolac—Dyspepsia—Epirubicin—uterine cancer	0.000151	0.000501	CcSEcCtD
Etodolac—Decreased appetite—Epirubicin—uterine cancer	0.000149	0.000495	CcSEcCtD
Etodolac—Hypotension—Doxorubicin—uterine cancer	0.000148	0.000492	CcSEcCtD
Etodolac—Fatigue—Epirubicin—uterine cancer	0.000148	0.000491	CcSEcCtD
Etodolac—Pain—Epirubicin—uterine cancer	0.000146	0.000487	CcSEcCtD
Etodolac—Constipation—Epirubicin—uterine cancer	0.000146	0.000487	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000144	0.00048	CcSEcCtD
Etodolac—Insomnia—Doxorubicin—uterine cancer	0.000143	0.000476	CcSEcCtD
Etodolac—Paraesthesia—Doxorubicin—uterine cancer	0.000142	0.000473	CcSEcCtD
Etodolac—Dyspnoea—Doxorubicin—uterine cancer	0.000141	0.000469	CcSEcCtD
Etodolac—Feeling abnormal—Epirubicin—uterine cancer	0.000141	0.000469	CcSEcCtD
Etodolac—Somnolence—Doxorubicin—uterine cancer	0.000141	0.000468	CcSEcCtD
Etodolac—Gastrointestinal pain—Epirubicin—uterine cancer	0.00014	0.000465	CcSEcCtD
Etodolac—Dyspepsia—Doxorubicin—uterine cancer	0.00014	0.000463	CcSEcCtD
Etodolac—Decreased appetite—Doxorubicin—uterine cancer	0.000138	0.000458	CcSEcCtD
Etodolac—Fatigue—Doxorubicin—uterine cancer	0.000137	0.000454	CcSEcCtD
Etodolac—Urticaria—Epirubicin—uterine cancer	0.000136	0.000452	CcSEcCtD
Etodolac—Pain—Doxorubicin—uterine cancer	0.000136	0.00045	CcSEcCtD
Etodolac—Constipation—Doxorubicin—uterine cancer	0.000136	0.00045	CcSEcCtD
Etodolac—Body temperature increased—Epirubicin—uterine cancer	0.000135	0.00045	CcSEcCtD
Etodolac—Abdominal pain—Epirubicin—uterine cancer	0.000135	0.00045	CcSEcCtD
Etodolac—Feeling abnormal—Doxorubicin—uterine cancer	0.000131	0.000434	CcSEcCtD
Etodolac—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00013	0.000431	CcSEcCtD
Etodolac—Hypersensitivity—Epirubicin—uterine cancer	0.000126	0.000419	CcSEcCtD
Etodolac—Urticaria—Doxorubicin—uterine cancer	0.000126	0.000418	CcSEcCtD
Etodolac—Abdominal pain—Doxorubicin—uterine cancer	0.000125	0.000416	CcSEcCtD
Etodolac—Body temperature increased—Doxorubicin—uterine cancer	0.000125	0.000416	CcSEcCtD
Etodolac—Asthenia—Epirubicin—uterine cancer	0.000123	0.000408	CcSEcCtD
Etodolac—Pruritus—Epirubicin—uterine cancer	0.000121	0.000403	CcSEcCtD
Etodolac—Diarrhoea—Epirubicin—uterine cancer	0.000117	0.000389	CcSEcCtD
Etodolac—Hypersensitivity—Doxorubicin—uterine cancer	0.000117	0.000388	CcSEcCtD
Etodolac—Asthenia—Doxorubicin—uterine cancer	0.000114	0.000378	CcSEcCtD
Etodolac—Dizziness—Epirubicin—uterine cancer	0.000113	0.000376	CcSEcCtD
Etodolac—Pruritus—Doxorubicin—uterine cancer	0.000112	0.000373	CcSEcCtD
Etodolac—Vomiting—Epirubicin—uterine cancer	0.000109	0.000362	CcSEcCtD
Etodolac—PTGS2—C-MYB transcription factor network—EP300—uterine cancer	0.000109	0.000976	CbGpPWpGaD
Etodolac—Diarrhoea—Doxorubicin—uterine cancer	0.000108	0.00036	CcSEcCtD
Etodolac—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000108	0.000974	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000108	0.000974	CbGpPWpGaD
Etodolac—Rash—Epirubicin—uterine cancer	0.000108	0.000359	CcSEcCtD
Etodolac—Dermatitis—Epirubicin—uterine cancer	0.000108	0.000358	CcSEcCtD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000107	0.000966	CbGpPWpGaD
Etodolac—Headache—Epirubicin—uterine cancer	0.000107	0.000356	CcSEcCtD
Etodolac—RXRA—Metabolism—STAR—uterine cancer	0.000106	0.000951	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AKR1B1—uterine cancer	0.000106	0.000951	CbGpPWpGaD
Etodolac—Dizziness—Doxorubicin—uterine cancer	0.000105	0.000348	CcSEcCtD
Etodolac—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000105	0.000941	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000105	0.000941	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—POLD1—uterine cancer	0.000105	0.000941	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000105	0.00094	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SRD5A2—uterine cancer	0.000104	0.000934	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—NDUFB11—uterine cancer	0.000104	0.000934	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000103	0.000926	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—SMAD3—uterine cancer	0.000102	0.000915	CbGpPWpGaD
Etodolac—Nausea—Epirubicin—uterine cancer	0.000102	0.000338	CcSEcCtD
Etodolac—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	0.000102	0.000914	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—NRAS—uterine cancer	0.000102	0.000913	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000101	0.000907	CbGpPWpGaD
Etodolac—Vomiting—Doxorubicin—uterine cancer	0.000101	0.000335	CcSEcCtD
Etodolac—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	0.0001	0.000901	CbGpPWpGaD
Etodolac—Rash—Doxorubicin—uterine cancer	9.99e-05	0.000332	CcSEcCtD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	9.99e-05	0.000897	CbGpPWpGaD
Etodolac—Dermatitis—Doxorubicin—uterine cancer	9.98e-05	0.000332	CcSEcCtD
Etodolac—Headache—Doxorubicin—uterine cancer	9.93e-05	0.00033	CcSEcCtD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	9.83e-05	0.000884	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—AKR1C1—uterine cancer	9.79e-05	0.00088	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—CXCL8—uterine cancer	9.65e-05	0.000867	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—SMAD3—uterine cancer	9.59e-05	0.000861	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	9.54e-05	0.000857	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	9.46e-05	0.00085	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	9.43e-05	0.000848	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—CDKN1B—uterine cancer	9.43e-05	0.000847	CbGpPWpGaD
Etodolac—Nausea—Doxorubicin—uterine cancer	9.41e-05	0.000313	CcSEcCtD
Etodolac—UGT1A9—Metabolism—AKR1B1—uterine cancer	9.22e-05	0.000828	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—STAR—uterine cancer	9.22e-05	0.000828	CbGpPWpGaD
Etodolac—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	9.12e-05	0.00082	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	9.11e-05	0.000819	CbGpPWpGaD
Etodolac—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	8.91e-05	0.000801	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—POLD1—uterine cancer	8.9e-05	0.0008	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	8.87e-05	0.000797	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	8.87e-05	0.000797	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—KRAS—uterine cancer	8.75e-05	0.000786	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—RRM2—uterine cancer	8.73e-05	0.000784	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—VEGFA—uterine cancer	8.66e-05	0.000778	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—DCN—uterine cancer	8.47e-05	0.000761	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AKR1C1—uterine cancer	8.33e-05	0.000748	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—ESR1—uterine cancer	8.31e-05	0.000747	CbGpPWpGaD
Etodolac—RXRA—Metabolism—POLD1—uterine cancer	8.3e-05	0.000746	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—NDUFB11—uterine cancer	8.25e-05	0.000742	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SRD5A2—uterine cancer	8.25e-05	0.000742	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	8.25e-05	0.000741	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	8.04e-05	0.000723	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	8.02e-05	0.00072	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CYP11A1—uterine cancer	7.98e-05	0.000717	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	7.96e-05	0.000715	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MET—uterine cancer	7.86e-05	0.000706	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AKR1C1—uterine cancer	7.77e-05	0.000698	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKR1B10—uterine cancer	7.66e-05	0.000689	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—TP53—uterine cancer	7.63e-05	0.000685	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.57e-05	0.00068	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—AKR1C3—uterine cancer	7.54e-05	0.000678	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—STAR—uterine cancer	7.52e-05	0.000675	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AKR1B1—uterine cancer	7.52e-05	0.000675	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—PGR—uterine cancer	7.49e-05	0.000673	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—HRAS—uterine cancer	7.43e-05	0.000668	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	7.43e-05	0.000668	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—RRM2—uterine cancer	7.42e-05	0.000667	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	7.39e-05	0.000664	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—POLD1—uterine cancer	7.23e-05	0.00065	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—DCN—uterine cancer	7.21e-05	0.000647	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	7.15e-05	0.000642	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—EZH2—uterine cancer	7.12e-05	0.00064	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	6.92e-05	0.000622	CbGpPWpGaD
Etodolac—RXRA—Metabolism—RRM2—uterine cancer	6.92e-05	0.000622	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CYP11A1—uterine cancer	6.79e-05	0.00061	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AKR1C1—uterine cancer	6.77e-05	0.000608	CbGpPWpGaD
Etodolac—RXRA—Metabolism—DCN—uterine cancer	6.72e-05	0.000604	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IRF1—uterine cancer	6.69e-05	0.000601	CbGpPWpGaD
Etodolac—ALB—Metabolism—SRD5A2—uterine cancer	6.68e-05	0.0006	CbGpPWpGaD
Etodolac—ALB—Metabolism—NDUFB11—uterine cancer	6.68e-05	0.0006	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—ESR2—uterine cancer	6.6e-05	0.000593	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.51e-05	0.000585	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.49e-05	0.000583	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	6.41e-05	0.000576	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AKR1C3—uterine cancer	6.41e-05	0.000576	CbGpPWpGaD
Etodolac—PTGS2—Disease—RNF43—uterine cancer	6.35e-05	0.000571	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CYP11A1—uterine cancer	6.33e-05	0.000569	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.12e-05	0.00055	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	6.06e-05	0.000544	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	6.04e-05	0.000542	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—RRM2—uterine cancer	6.03e-05	0.000542	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AKR1C3—uterine cancer	5.98e-05	0.000537	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AKR1B1—uterine cancer	5.97e-05	0.000536	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—STAR—uterine cancer	5.97e-05	0.000536	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TP53—uterine cancer	5.92e-05	0.000532	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	5.9e-05	0.000531	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—POLD1—uterine cancer	5.9e-05	0.00053	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.9e-05	0.00053	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—STK11—uterine cancer	5.87e-05	0.000528	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CYP19A1—uterine cancer	5.87e-05	0.000528	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—DCN—uterine cancer	5.86e-05	0.000526	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—ERBB2—uterine cancer	5.74e-05	0.000516	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	5.63e-05	0.000506	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AKR1C1—uterine cancer	5.52e-05	0.000496	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CYP11A1—uterine cancer	5.52e-05	0.000496	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NDUFB11—uterine cancer	5.47e-05	0.000491	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SRD5A2—uterine cancer	5.47e-05	0.000491	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—CDKN2B—uterine cancer	5.37e-05	0.000483	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	5.33e-05	0.000479	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.31e-05	0.000477	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKR1C1—uterine cancer	5.23e-05	0.00047	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AKR1C3—uterine cancer	5.21e-05	0.000468	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—CTNNB1—uterine cancer	5.02e-05	0.000451	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.01e-05	0.00045	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—STK11—uterine cancer	4.99e-05	0.000449	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CYP19A1—uterine cancer	4.99e-05	0.000449	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—RRM2—uterine cancer	4.92e-05	0.000442	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—SMAD3—uterine cancer	4.9e-05	0.000441	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKR1B1—uterine cancer	4.83e-05	0.000434	CbGpPWpGaD
Etodolac—ALB—Metabolism—STAR—uterine cancer	4.83e-05	0.000434	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—DCN—uterine cancer	4.77e-05	0.000429	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.77e-05	0.000429	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—POLD1—uterine cancer	4.68e-05	0.000421	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—EP300—uterine cancer	4.67e-05	0.00042	CbGpPWpGaD
Etodolac—RXRA—Metabolism—STK11—uterine cancer	4.66e-05	0.000419	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CYP19A1—uterine cancer	4.66e-05	0.000419	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	4.53e-05	0.000407	CbGpPWpGaD
Etodolac—PTGS2—Disease—DCN—uterine cancer	4.52e-05	0.000407	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP11A1—uterine cancer	4.5e-05	0.000404	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—VEGFA—uterine cancer	4.42e-05	0.000397	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—MTHFR—uterine cancer	4.41e-05	0.000397	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AKR1C1—uterine cancer	4.38e-05	0.000394	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.37e-05	0.000393	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—NRAS—uterine cancer	4.37e-05	0.000393	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AKR1C3—uterine cancer	4.25e-05	0.000382	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.17e-05	0.000375	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	4.17e-05	0.000374	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—STK11—uterine cancer	4.06e-05	0.000365	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CYP19A1—uterine cancer	4.06e-05	0.000365	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	4.03e-05	0.000362	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKR1C3—uterine cancer	4.03e-05	0.000362	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—ESR1—uterine cancer	4e-05	0.00036	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—STAR—uterine cancer	3.95e-05	0.000355	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKR1B1—uterine cancer	3.95e-05	0.000355	CbGpPWpGaD
Etodolac—PTGS2—Disease—HMGA1—uterine cancer	3.92e-05	0.000353	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.91e-05	0.000351	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—RRM2—uterine cancer	3.9e-05	0.000351	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	3.84e-05	0.000345	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.81e-05	0.000342	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—DCN—uterine cancer	3.79e-05	0.00034	CbGpPWpGaD
Etodolac—ALB—Metabolism—POLD1—uterine cancer	3.79e-05	0.00034	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—KRAS—uterine cancer	3.76e-05	0.000338	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—MTHFR—uterine cancer	3.75e-05	0.000337	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.63e-05	0.000326	CbGpPWpGaD
Etodolac—PTGS2—Disease—FBXW7—uterine cancer	3.59e-05	0.000322	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP11A1—uterine cancer	3.57e-05	0.000321	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKR1C1—uterine cancer	3.54e-05	0.000318	CbGpPWpGaD
Etodolac—RXRA—Metabolism—MTHFR—uterine cancer	3.5e-05	0.000315	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.4e-05	0.000306	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AKR1C3—uterine cancer	3.37e-05	0.000303	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP19A1—uterine cancer	3.31e-05	0.000297	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—STK11—uterine cancer	3.31e-05	0.000297	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—HRAS—uterine cancer	3.2e-05	0.000287	CbGpPWpGaD
Etodolac—ALB—Metabolism—RRM2—uterine cancer	3.16e-05	0.000284	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.11e-05	0.000279	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—POLD1—uterine cancer	3.1e-05	0.000279	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.09e-05	0.000277	CbGpPWpGaD
Etodolac—ALB—Metabolism—DCN—uterine cancer	3.07e-05	0.000275	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—MTHFR—uterine cancer	3.05e-05	0.000274	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	3e-05	0.000269	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.96e-05	0.000266	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKR1C1—uterine cancer	2.9e-05	0.000261	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP11A1—uterine cancer	2.89e-05	0.00026	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—AKT1—uterine cancer	2.82e-05	0.000254	CbGpPWpGaD
Etodolac—PTGS2—Disease—CDKN2B—uterine cancer	2.81e-05	0.000253	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKR1C3—uterine cancer	2.73e-05	0.000245	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.69e-05	0.000242	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP19A1—uterine cancer	2.63e-05	0.000236	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—STK11—uterine cancer	2.63e-05	0.000236	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—RRM2—uterine cancer	2.58e-05	0.000232	CbGpPWpGaD
Etodolac—PTGS2—Disease—SMAD3—uterine cancer	2.57e-05	0.000231	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—DCN—uterine cancer	2.51e-05	0.000225	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—MTHFR—uterine cancer	2.49e-05	0.000223	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.47e-05	0.000222	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTEN—uterine cancer	2.46e-05	0.000221	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	2.45e-05	0.00022	CbGpPWpGaD
Etodolac—PTGS2—Disease—FGFR2—uterine cancer	2.45e-05	0.00022	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP11A1—uterine cancer	2.36e-05	0.000212	CbGpPWpGaD
Etodolac—PTGS2—Disease—MTHFR—uterine cancer	2.36e-05	0.000212	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.35e-05	0.000211	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—EP300—uterine cancer	2.34e-05	0.00021	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKR1C3—uterine cancer	2.23e-05	0.000201	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.19e-05	0.000197	CbGpPWpGaD
Etodolac—ALB—Metabolism—STK11—uterine cancer	2.12e-05	0.000191	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP19A1—uterine cancer	2.12e-05	0.000191	CbGpPWpGaD
Etodolac—ALB—Hemostasis—EP300—uterine cancer	2.09e-05	0.000188	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTEN—uterine cancer	2.09e-05	0.000188	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.99e-05	0.000179	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—EP300—uterine cancer	1.99e-05	0.000179	CbGpPWpGaD
Etodolac—ALB—Hemostasis—VEGFA—uterine cancer	1.98e-05	0.000178	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—MTHFR—uterine cancer	1.97e-05	0.000177	CbGpPWpGaD
Etodolac—ALB—Hemostasis—NRAS—uterine cancer	1.95e-05	0.000176	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTEN—uterine cancer	1.95e-05	0.000175	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.9e-05	0.000171	CbGpPWpGaD
Etodolac—RXRA—Metabolism—EP300—uterine cancer	1.86e-05	0.000167	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.74e-05	0.000156	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—STK11—uterine cancer	1.74e-05	0.000156	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.74e-05	0.000156	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CA—uterine cancer	1.73e-05	0.000156	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTEN—uterine cancer	1.7e-05	0.000152	CbGpPWpGaD
Etodolac—ALB—Hemostasis—KRAS—uterine cancer	1.68e-05	0.000151	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.63e-05	0.000147	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—EP300—uterine cancer	1.62e-05	0.000145	CbGpPWpGaD
Etodolac—ALB—Metabolism—MTHFR—uterine cancer	1.6e-05	0.000143	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.56e-05	0.00014	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CA—uterine cancer	1.55e-05	0.000139	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERBB2—uterine cancer	1.54e-05	0.000138	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TP53—uterine cancer	1.5e-05	0.000134	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CA—uterine cancer	1.47e-05	0.000132	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—AKT1—uterine cancer	1.44e-05	0.00013	CbGpPWpGaD
Etodolac—ALB—Hemostasis—HRAS—uterine cancer	1.43e-05	0.000128	CbGpPWpGaD
Etodolac—PTGS2—Disease—CDKN1B—uterine cancer	1.42e-05	0.000128	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—AKT1—uterine cancer	1.42e-05	0.000127	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.41e-05	0.000126	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTEN—uterine cancer	1.38e-05	0.000124	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CA—uterine cancer	1.37e-05	0.000123	CbGpPWpGaD
Etodolac—PTGS2—Disease—CTNNB1—uterine cancer	1.35e-05	0.000121	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—EP300—uterine cancer	1.32e-05	0.000119	CbGpPWpGaD
Etodolac—PTGS2—Disease—PTEN—uterine cancer	1.31e-05	0.000118	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—MTHFR—uterine cancer	1.31e-05	0.000117	CbGpPWpGaD
Etodolac—ALB—Hemostasis—AKT1—uterine cancer	1.26e-05	0.000113	CbGpPWpGaD
Etodolac—PTGS2—Disease—EP300—uterine cancer	1.25e-05	0.000112	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AKT1—uterine cancer	1.2e-05	0.000108	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CA—uterine cancer	1.2e-05	0.000108	CbGpPWpGaD
Etodolac—PTGS2—Disease—NRAS—uterine cancer	1.17e-05	0.000105	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.15e-05	0.000103	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AKT1—uterine cancer	1.12e-05	0.000101	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PTEN—uterine cancer	1.1e-05	9.87e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—EP300—uterine cancer	1.05e-05	9.41e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—KRAS—uterine cancer	1.01e-05	9.05e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AKT1—uterine cancer	9.78e-06	8.79e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CA—uterine cancer	9.76e-06	8.77e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CA—uterine cancer	9.25e-06	8.31e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTEN—uterine cancer	8.88e-06	7.98e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—HRAS—uterine cancer	8.56e-06	7.69e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—EP300—uterine cancer	8.47e-06	7.61e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AKT1—uterine cancer	7.97e-06	7.16e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CA—uterine cancer	7.75e-06	6.96e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKT1—uterine cancer	7.56e-06	6.79e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTEN—uterine cancer	7.27e-06	6.53e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—EP300—uterine cancer	6.93e-06	6.23e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AKT1—uterine cancer	6.33e-06	5.69e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CA—uterine cancer	6.27e-06	5.63e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CA—uterine cancer	5.13e-06	4.61e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKT1—uterine cancer	5.12e-06	4.6e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKT1—uterine cancer	4.19e-06	3.77e-05	CbGpPWpGaD
